Coming May 2025
Get Early Access
aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
© aVenture Investment Company, 2025. All rights reserved.
44 Tehama St, San Francisco, CA 94105
aVenture Investment Company ("aVenture") is an independent venture capital research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals.
While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision.
aVenture does not offer investment advisory services and is not registered as an investment adviser. The data provided by aVenture does not constitute recommendations or advice, whether by methodology or a statement written by a staff member of aVenture.
Links to external websites do not imply endorsement or affiliation with aVenture. References or links to providers offering the ability to invest in a primary or secondary transaction in a company are for convenience purposes only. They are not solicitations or offers to buy or sell an investment. Remember that past performance does not guarantee future results, and venture capital and private assets should be a contributory part of a diversified portfolio.
322 employees
US-based Synthego Corp. provides software solutions for biological research, primarily serving California.
HQ
Founded
2012
Founded in Menlo Park, California, Synthego is a biotechnology company focused on making CRISPR gene editing more accessible and efficient. The company's core mission is to accelerate the pace of scientific discovery by providing high-quality, reliable tools for genome engineering. Synthego offers a range of products, including multi-guide RNA kits and custom-made edited cells, designed to simplify and streamline the CRISPR process for researchers. Their market focus includes academic institutions, pharmaceutical companies, and biotech firms primarily in California but with a growing global presence.
Notable affiliated individuals include co-founders Paul and Michael Dabrowski, who have backgrounds in engineering and software development. Synthego has attracted significant investment from prominent venture capital firms such as 8VC and Founders Fund. Key achievements include the development of automated platforms for RNA synthesis and cell engineering, which have significantly reduced the time and cost associated with CRISPR research. Overall, Synthego has made a substantial impact on the field of genetic engineering by democratizing access to advanced genome editing technologies.
Operating Status
Active
Ownership Type(s)
Venture Capital, Equity
Main Product(s)
Gene Editing, Crispr Kits
Technology
Biotech, Crispr
Tags
SaaS, Platform
Model Types
Transactional, Recurring
Customer Type(s)
Enterprise, Education
Geographic Exposure
United States
When was Synthego founded?
Synthego was founded in 2012.
Where is Synthego's headquarters located?
Synthego's headquarters is located in Redwood City, CA, US.
When was Synthego's last funding round?
Synthego's most recent funding round was for $200M (USD) in February 2022.
How many employees does Synthego have?
Synthego has 322 employees as of Feb 5, 2024.
How much has Synthego raised to-date?
As of July 05, 2023, Synthego has raised a total of $460.5M (USD) since Feb 17, 2022.
Add Comparison
Total Raised to Date
$460.5M
USD
Last Update Feb 17, 2022
Last Deal Details
$200M
USD
Feb 17, 2022
Series E
Current Employees
322
Last updated: Feb 5, 2024
No location information available for this company.
Locations
Source(s): This page includes data and analysis provided by the company, OpenAI, and our research analysts